naohiko anzai
Chiba University
Chiba, Japan
Review Editor
Molecular Signalling and Pathways
Chiba University
Chiba, Japan
Review Editor
Molecular Signalling and Pathways
University of Southern California
Los Angeles, United States
Review Editor
Molecular Signalling and Pathways
Karolinska Institutet (KI)
Solna, Sweden
Review Editor
Molecular Signalling and Pathways
Department of Pharmacology and Toxicology, Faculty of Medicine, Complutense University of Madrid
Madrid, Spain
Review Editor
Molecular Signalling and Pathways
University of Salamanca
Salamanca, Spain
Review Editor
Molecular Signalling and Pathways
University College London
London, United Kingdom
Review Editor
Molecular Signalling and Pathways
Chobanian & Avedisian School of Medicine, Boston University
Boston, United States
Review Editor
Molecular Signalling and Pathways
Tel Aviv University
Tel Aviv, Israel
Review Editor
Molecular Signalling and Pathways
Dell Medical School, The University of Texas at Austin
Austin, United States
Review Editor
Molecular Signalling and Pathways
Leibniz-Institut für Molekulare Pharmakologie (FMP)
Berlin, Germany
Review Editor
Molecular Signalling and Pathways
UMR7275 Institut de Pharmacologie Moléculaire et Cellulaire (IPMC)
Valbonne, France
Review Editor
Molecular Signalling and Pathways
Brigham and Women's Hospital, Harvard Medical School
Boston, United States
Review Editor
Molecular Signalling and Pathways
Indian Institute of Science Education and Research Mohali
Mohali, India
Review Editor
Molecular Signalling and Pathways
Swansea University
Swansea, United Kingdom
Review Editor
Molecular Signalling and Pathways
Dewpoint Therapeutics
Boston, United States
Review Editor
Molecular Signalling and Pathways
Università telematica San Raffaele
Rome, Italy
Review Editor
Molecular Signalling and Pathways